CVRx, Inc. (CVRX)
3.05
+0.04
(+1.33%)
USD |
NASDAQ |
Sep 04, 16:00
3.10
+0.05
(+1.64%)
After-Hours: 20:00
CVRx Research and Development Expense (Quarterly) : 3.13M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.13M |
| March 31, 2026 | 3.084M |
| December 31, 2025 | 3.00M |
| September 30, 2025 | 3.146M |
| June 30, 2025 | 2.469M |
| March 31, 2025 | 2.517M |
| December 31, 2024 | 2.805M |
| September 30, 2024 | 2.504M |
| June 30, 2024 | 2.765M |
| March 31, 2024 | 3.057M |
| December 31, 2023 | 2.241M |
| September 30, 2023 | 2.696M |
| June 30, 2023 | 3.28M |
| Date | Value |
|---|---|
| March 31, 2023 | 3.416M |
| December 31, 2022 | 3.046M |
| September 30, 2022 | 2.293M |
| June 30, 2022 | 2.355M |
| March 31, 2022 | 2.258M |
| December 31, 2021 | 1.797M |
| September 30, 2021 | 1.699M |
| June 30, 2021 | 2.255M |
| March 31, 2021 | 1.75M |
| December 31, 2020 | 0.51M |
| September 30, 2020 | 1.50M |
| June 30, 2020 | 2.131M |
| March 31, 2020 | 2.269M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| NeuroPace, Inc. | 6.898M |
| Accuray, Inc. | 7.707M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 14.86M |
| ResMed, Inc. | 105.73M |